A potential role of preexisting inflammation in the development of acute myelopathy following CAR T-cell therapy for diffuse large B-cell lymphoma

Current Research in Translational Medicine ◽

10.1016/j.retram.2021.103331 ◽

2022 ◽

Vol 70 (2) ◽

pp. 103331

Author(s):

David Beauvais ◽

Adeline Cozzani ◽

Anne-Sophie Blaise ◽

Anne-Sophie Moreau ◽

Pauline Varlet ◽

...

Keyword(s):

Cell Therapy ◽

Potential Role ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Download Full-text

The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy

10.1097/hs9.0000000000000295 ◽

2019 ◽

Vol 3 (6) ◽

pp. e295 ◽

Author(s):

Lazaros J. Lekakis ◽

Craig H. Moskowitz

Keyword(s):

Stem Cell ◽

Cell Therapy ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Download Full-text

Efficacy of Chimeric Antigen Receptor (CAR) T-Cell Therapy, Axicabtagene Ciloleucel (axi-cel), in Patients with Refractory Large B-Cell Lymphoma (LBCL)

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00519-4 ◽

2021 ◽

Vol 27 (3) ◽

pp. S403-S404

Author(s):

Sairah Ahmed ◽

Paolo Strati ◽

Luis Fayad ◽

Frederick Hagemeister ◽

Hun Ju Lee ◽

...

Keyword(s):

Cell Therapy ◽

B Cell ◽

Chimeric Antigen Receptor ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Download Full-text

Outcomes of Treatment with the Chimeric Antigen Receptor (CAR) T Cell Therapy Lisocabtagene Maraleucel (liso-cel) at Nonuniversity Medical Centers (NMCs): Initial Results from the Outreach Study in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Transplantation and Cellular Therapy ◽

10.1016/s2666-6367(21)00251-7 ◽

2021 ◽

Vol 27 (3) ◽

pp. S203-S204

Author(s):

John Godwin ◽

Cesar O. Freytes ◽

Michael Maris ◽

Don A. Stevens ◽

Daanish Hoda ◽

...

Keyword(s):

Cell Therapy ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Medical Centers ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Initial Results ◽

Download Full-text

Incidence and Management of Effusions before and after CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy in Large B-Cell Lymphoma

Transplantation and Cellular Therapy ◽

10.1016/j.jtct.2020.12.025 ◽

2020 ◽

Author(s):

Abu-Sayeef Mirza ◽

Ambuj Kumar ◽

Hamza Hashmi ◽

Franco Garcia ◽

Constantine N. Logothetis ◽

...

Keyword(s):

Cell Therapy ◽

Chimeric Antigen Receptor ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Before And After ◽

Download Full-text

Salvage Radiation Treatment for Primary Refractory Diffuse Large B-cell Lymphoma After Chimeric Antigen Receptor (CAR) T-cell Therapy: A Case Report

Anticancer Research ◽

10.21873/anticanres.15152 ◽

2021 ◽

Vol 41 (7) ◽

pp. 3635-3638

Author(s):

KAIDI WANG ◽

ARPAN V. PRABHU ◽

APPALANAIDU SASAPU ◽

GARY D. LEWIS

Keyword(s):

Case Report ◽

Cell Therapy ◽

Radiation Treatment ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Download Full-text

Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma

10.1159/isbn.978-3-318-06935-8 ◽

2021 ◽

Author(s):

Richard J. Buka ◽

Dee Moloney

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Download Full-text

Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma

Leukemia & Lymphoma ◽

10.1080/10428194.2019.1691201 ◽

2019 ◽

Vol 61 (4) ◽

pp. 799-807 ◽

Author(s):

Kirk E. Cahill ◽

Michael J. Leukam ◽

Peter A. Riedell

Keyword(s):

Cell Therapy ◽

Patient Selection ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Selection For ◽

Download Full-text

PCN90 ASSESSMENT OF UTILITIES FOR ADVERSE EVENTS (AES) ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN LARGE B-CELL LYMPHOMA (LBCL)

Value in Health ◽

10.1016/j.jval.2020.04.1590 ◽

2020 ◽

Vol 23 ◽

pp. S39

Author(s):

T. Howell ◽

L. Matza ◽

M.P. Jun ◽

J. Garcia ◽

A. Powers ◽

...

Keyword(s):

Adverse Events ◽

Cell Therapy ◽

Chimeric Antigen Receptor ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Download Full-text

Rapid relapse of large B‐cell lymphoma after CD19 directed CAR‐T‐cell therapy due to CD‐19 antigen loss

American Journal of Hematology ◽

10.1002/ajh.25591 ◽

2019 ◽

Vol 94 (10) ◽

Author(s):

Ali Bukhari ◽

Firas El Chaer ◽

Rima Koka ◽

Zeba Singh ◽

Elizabeth Hutnick ◽

...

Keyword(s):

Cell Therapy ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Antigen Loss ◽

Download Full-text

Retrospective Analysis of ZUMA-1 Data Indicates Better Prognosis for Patients With Large B-Cell Lymphoma Who Relapse > 3 Months Post-CAR T-Cell Therapy

Default Digital Object Group ◽

10.1200/adn.19.190205 ◽

2019 ◽

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

T Cell Therapy ◽

Large B Cell Lymphoma ◽

Car T Cell Therapy ◽

Car T ◽

Download Full-text